Biophytis SA presented its phase 3 protocol aimed at demonstrating the potential of RuvembriTM in the treatment of sarcopenia at the International Conference on Frailty and Sarcopenia Research, held from March 20 to 22, 2024 in Albuquerque, NM, USA.
March 22, 2024
· 4 min read